Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Depreciation and Depletion (2016 - 2025)

American Healthcare REIT (AHR) has disclosed Depreciation and Depletion for 10 consecutive years, with $42.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion rose 7.94% year-over-year to $42.9 million, compared with a TTM value of $156.4 million through Dec 2025, up 3.34%, and an annual FY2025 reading of $156.4 million, up 3.34% over the prior year.
  • Depreciation and Depletion was $42.9 million for Q4 2025 at American Healthcare REIT, up from $39.6 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $42.9 million in Q4 2025 and bottomed at $24.2 million in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $35.3 million, with a median of $36.9 million recorded in 2023.
  • Peak annual rise in Depreciation and Depletion hit 212.47% in 2021, while the deepest fall reached 47.38% in 2021.
  • Year by year, Depreciation and Depletion stood at $35.4 million in 2021, then grew by 4.99% to $37.2 million in 2022, then increased by 1.18% to $37.6 million in 2023, then rose by 5.61% to $39.7 million in 2024, then rose by 7.94% to $42.9 million in 2025.
  • Business Quant data shows Depreciation and Depletion for AHR at $42.9 million in Q4 2025, $39.6 million in Q3 2025, and $37.3 million in Q2 2025.